Nathaniel Xander

Nathaniel Xander is an Associate Scientist at Chimeron Bio since April 2022, focusing on quality control of self-amplifying RNA therapeutics for vaccines and rare diseases. Currently training AI models for molecular biology inquiries at Outlier, Nathaniel also previously served as a Bench Scientist at GSK, where novel drug targets were characterized using wet lab techniques. Earlier experience includes roles as a Laboratory Assistant and Undergraduate Research Assistant at Temple University, where research investigated disease mechanisms through blood and cell sample analysis. Nathaniel holds a Master's degree in Biotechnology and a Bachelor's degree in Biochemistry from Temple University.